Boehringer operating income edges up on Jardiance, animal health Ruchika Sharma6 April 2022 9:00 AM ISTFrankfurt: Germany's unlisted Boehringer Ingelheim said operating income rose 1.8% in 2021, driven by more prescriptions of diabetes drug Jardiance...
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
FDA approves Jardiance for heart failure in adults Dr. Kamal Kant Kohli25 Feb 2022 1:54 AM ISTThe U.S. Food and Drug Administration has approved diabetes drug Jardiance for heart failure in adults. This will help reduce the risk of...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 29/October/2021 Roshni Dhar30 Oct 2021 11:09 AM ISTHere are Top Health Stories of the dayMadras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelinesSlamming the...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 25/October/2021 Roshni Dhar25 Oct 2021 4:23 PM ISTHere are Top Health Stories of the dayDoctors cannot function under threat of being harassed, beaten up: High CourtThe Punjab and Haryana High Court...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
FDA approves empagliflozin for heart failure with reduced ejection fraction in adults Dr. Kamal Kant Kohli21 Aug 2021 7:15 AM ISTThe U.S. Food and Drug Administration has approved Jardiance (empagliflozin) to reduce the risk of cardiovascular mortality plus hospitalization for...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 9:00 AM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
Lilly diabetes drug slashes deaths in patients with heart risk Meghna A Singhania20 Sept 2015 1:05 PM ISTEli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack and stroke, a finding that...
Diabetes Drug Jardiance may also reduce risk of heart attacks, strokes and CVD Meghna A Singhania23 Aug 2015 6:33 AM ISTTRENTON, N.J. - For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer...
